Search Within

Heiko Schoder

  1. "2023"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (17)
  3. Guidelines (2)
  4. Research Letter (2)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Molecular Imaging and Therapy Service (42)
  2. Radiology, Department of (42)
  3. Department of Medicine (28)
  4. Sloan Kettering Institute Postdocs (27)
  5. Hematologic Malignancies, Division of (18)
  6. Survivorship Research (18)

More Groups

People
  1. Gilles Salles (12)
  2. Maria Palomba (11)
  3. Joachim Yahalom (10)
  4. Andrew Zelenetz (9)
  5. Audrey Mauguen (9)
  6. Brandon Imber (8)

More People

Years
  1. 2023 (42)
Publications
  1. Journal of Nuclear Medicine (8)
  2. European Journal of Nuclear Medicine and Molecular Imaging (7)
  3. Blood (6)
  4. Hematological Oncology (3)
  5. American Journal of Physiology - Endocrinology and Metabolism (1)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. Springer (10)
  2. Society of Nuclear Medicine (8)
  3. American Society of Hematology (7)
  4. Wiley Blackwell (4)
  5. Elsevier Inc. (3)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (42)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT
    Journal Article

    McLaughlin, L. A.; Yildirim, O.; Rosenblum, M. K.; Imber, B. S.; Haseltine, J. M.; Zelefsky, M. J.; Schöder, H.; Morris, M. J.; Rafelson, W. M.; Krebs, S.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Joint EANM/SNMMI procedure guideline for the use of (177)Lu-labeled PSMA-targeted radioligand-therapy ((177(Lu-PSMA-RLT)
    Guidelines

    Kratochwil, C.; Fendler, W. P.; Eiber, M.; Hofman, M. S.; Emmett, L.; Calais, J.; Osborne, J. R.; Iravani, A.; Koo, P.; Lindenberg, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Occupational dose reductions during FDG administrations at Memorial Sloan Kettering Cancer Center
    Meeting Abstract

    Bierman, D. A.; Williamson, M.; Miodownik, D.; Quinn, B.; Schöder, H.; Davie, S.
    Health Physics (2023)

    Fulltext@MSK | Save
  • PET‐adapted therapy with nivolumab plus adriamycin, vinblastine, and dacarbazine for newly diagnosed stage III or IV Hodgkin Lymphoma
    Meeting Abstract

    Moskowitz, A.; Savage, K.; Feldman, T.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis
    Journal Article

    Torka, P.; Pederson, L. D.; Knopp, M. V.; Poon, D.; Zhang, J.; Kahl, B. S.; Higley, H. R.; Kelloff, G.; Friedberg, J. W.; Schwartz, L. H.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Long-term prognostic value of (82)Rb PET/CT-determined myocardial perfusion and flow reserve in cancer patients
    Journal Article

    Fox, J. J.; Mauguen, A.; Ito, K.; Gupta, D.; Yu, A.; Schindler, T. H.; Strauss, H. W.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
    Journal Article

    Yu, Y.; Schöder, H.; Zakeri, K.; Chen, L.; Kang, J. J.; McBride, S. M.; Tsai, C. J.; Gelblum, D. Y.; Boyle, J. O.; Cracchiolo, J. R.; more...
    Oral Oncology (2023)

    Fulltext@MSK | Save